Yalan Zhou

3PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 30, 2026
Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine.

|Apr 15, 2025
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.

Ya-Lan Zhou, Jin-Qiao Zhang, Wei Wang

|Nov 22, 2023
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics.

Ya-Lan Zhou, Ming-Yue Zhao, Robert Peter Gale

Pageof 1

Frequent Collaborators

1 joint publications

Robert Peter Gale

1 joint publications

Qian Jiang

1 joint publications

Jia-Yue Qin

1 joint publications

Lan-Ping Xu